Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Breast Cancer and the Workforce: Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life (BCW)
1 other identifier
observational
935
1 country
12
Brief Summary
The purpose of this study is to learn more about how being treated for breast cancer affects patients' employment, financial situation, and quality of life on a short-term basis and on a long term basis. Most studies of employment after breast cancer have focused on Caucasian women.This study will evaluate the impact of breast cancer on the lives of women from different ethnic groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2010
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 27, 2010
CompletedFirst Posted
Study publicly available on registry
May 31, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJune 26, 2025
June 1, 2025
16 years
May 27, 2010
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the impact of breast cancer on (a) employment status, (b) financial situation, and (c) QoL.
3 years
Secondary Outcomes (2)
To identify barriers to employment and correlates of employment status, financial situation, and QoL.
3 years
To develop the methodology to evaluate discrimination in the labor market using a validated instrument and to determine whether or not labor market discrimination is exacerbated by a diagnosis of breast cancer.
3 years
Study Arms (2)
Breast cancer survivors
Women being treated for stage I-III breast cancer who were employed prior to this diagnosis will be recruited in their physicians' offices.
Comparison group
Peer controls will be nominated by participants in the breast cancer survivor group or recruited by community outreach and matched for age, language, and ethnicity. This cohort is no longer recruiting.
Interventions
Patients will be asked to complete a questionnaire at baseline, and then one at follow up, 3-4 months after treatment completion. The patient will be contacted one and two years after the completion of their follow up questionnaire for a brief one-question survey regarding current employment status. A member of the study team will call a subset of patients who have completed both baseline and follow-up surveys to clarify responses to previous questions. Patients will be considered lost to follow- up if surveys A or C have not been completed two years from the participant's consent date (participants who enroll but do not complete survey A are not prompted for survey C). Deviations will not be filed until the end of the study, as there are opportunities over the course of study follow- up to collect previously missing information.
Eligibility Criteria
We will recruit participants from Memorial Sloan-Kettering Cancer Center (MSKCC), four of its community-based outpatient treatment centers, and four urban community hospitals and clinics that serve large populations of ethnic minorities in New York City. The MSKCC outpatient regional sites are located in New Jersey (Basking Ridge, Monmouth) and New York, with two in Long Island (Commack and Rockville Centre) and another in Westchester County.
You may qualify if:
- Breast cancer survivors
- Pathologic diagnosis of stage I-III breast cancer
- Paid employment (full time or part time) at time of consent or in the three months prior to diagnosis
- Age 18 to 64 years (inclusive)
- The ability to give informed consent in Chinese (Mandarin), English, Korean, or Spanish.at MSK, New York Presbyterian Queens and Queens Medical Associates At NYC Health \& Hospitals/ Lincoln Medical Center, patients must be able to give consent in English or Spanish.
- At the time of enrollment, participants must still be undergoing chemotherapy, undergoing radiation therapy, or planning surgery unless surgery is to be the only treatment modality. Those for whom treatment consists of surgery alone may have had their operation no more than 2 months prior to study enrollment. Participants need not have undergone surgical reconstruction prior to enrollment if the plan is to delay this procedure until after primary treatment is completed.
- Comparison group
- Paid employment (full time or part time) at the time of consent
- Age 18 to 64 years (inclusive) and within an age range that is 5 years above or below that of the nominating or matched survivor
- The ability to give informed consent in the same language as the nominating survivor
- Membership in the same ethnic group as the nominating survivor
- Not treated for cancer in the past year (other than non-melanoma skin cancer)
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- The City College of New Yorkcollaborator
- NYC Health & Hospitals/ Lincoln Medical Centercollaborator
- New York Presbyterian Queenscollaborator
- New York City Health and Hospitals Corporationcollaborator
- Queens Medical Associatescollaborator
Study Sites (12)
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748, United States
Woodhull Medical and Mental Health Center
Brooklyn, New York, 11206, United States
Memorial Sloan Kettering Commack
Commack, New York, 11725, United States
Queens Medical Associates
Fresh Meadows, New York, 11366, United States
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
Memorial Sloan Kettering at Ralph Lauren
New York, New York, 10035, United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Bellevue Hospital Center
New York, New York, United States
New York Presbyterian Queens
Queens, New York, 11355, United States
NYC Health & Hospitals /Lincoln Medical Center
The Bronx, New York, 10451, United States
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victoria Blinder, M.D., M.Sc.
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2010
First Posted
May 31, 2010
Study Start
May 1, 2010
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
June 26, 2025
Record last verified: 2025-06